Immediate Impact
11 standout
Citing Papers
Antimicrobial resistance: a concise update
2024 Standout
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Works of Xiaoju Lv being referenced
Prulifloxacin versus Levofloxacin in the Treatment of Respiratory and Urinary Tract Infections: A Multicentre, Double-Blind, Randomized Controlled Clinical Trial
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiaoju Lv | 91 | 93 | 24 | 26 | 25 | 196 | |
| Terri Stillwell | 123 | 52 | 35 | 35 | 16 | 288 | |
| Rosa Díaz | 45 | 44 | 23 | 29 | 14 | 211 | |
| Dag Torfoss | 58 | 64 | 20 | 26 | 19 | 279 | |
| Hugo Guillermo Ternavasio‐de la Vega | 76 | 57 | 25 | 9 | 16 | 193 | |
| Paul E. Bunce | 116 | 126 | 42 | 11 | 22 | 299 | |
| Tercan Us | 100 | 56 | 20 | 11 | 31 | 281 | |
| Hideki Ikeda | 83 | 77 | 21 | 18 | 32 | 233 | |
| Mustafa Zahir Bakıcı | 96 | 63 | 25 | 14 | 31 | 280 | |
| Hari Polenakovik | 60 | 110 | 27 | 9 | 27 | 205 | |
| Balram Ji Omar | 57 | 103 | 34 | 13 | 38 | 283 |
All Works
Login with ORCID to disown or claim papers
Loading papers...